🔗 Share this article

Texas Attorney General Paxton is suing the manufacturers of Tylenol, alleging the corporations withheld potential risks that the pain reliever created to children's cognitive development.

This legal action arrives a month after Donald Trump advocated an unsubstantiated connection between consuming Tylenol - also known as paracetamol - while pregnant and autism spectrum disorder in children.

Paxton is filing suit against the pharmaceutical giant, which previously sold the drug, the sole analgesic approved for pregnant women, and Kenvue, which now manufacturers it.

In a statement, he claimed they "misled consumers by gaining financially from discomfort and pushing pills regardless of the potential hazards."

Kenvue asserts there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening countless individuals to boost earnings," Paxton, a Republican, said.

The company commented that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its official site, Kenvue also said it had "continuously evaluated the pertinent research and there is insufficient valid information that demonstrates a verified association between using acetaminophen and autism."

Groups representing medical professionals and health professionals agree.

The leading OB-GYN organization has said acetaminophen - the primary component in Tylenol - is among limited choices for women during pregnancy to manage discomfort and elevated temperature, which can pose major wellness concerns if not addressed.

"In over twenty years of studies on the consumption of paracetamol in gestation, not a single reputable study has conclusively proven that the use of paracetamol in any period of pregnancy results in neurological conditions in offspring," the association said.

The court filing mentions recent announcements from the Trump administration in claiming the drug is reportedly hazardous.

Last month, the former president raised alarms from public health officials when he instructed pregnant women to "resist strongly" not to consume Tylenol when unwell.

The FDA then issued a notice that medical professionals should think about restricting the consumption of acetaminophen, while also mentioning that "a proven link" between the drug and autism in minors has remains unverified.

The Health Department head Kennedy, who oversees the Food and Drug Administration, had vowed in April to undertake "comprehensive study program" that would identify the source of autism in a short period.

But experts warned that identifying a single cause of autism - believed by scientists to be the outcome of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism is a type of lifelong neurodivergence and condition that influences how people experience and relate to the surroundings, and is diagnosed using physician assessments.

In his court filing, Paxton - aligned with the former president who is campaigning for US Senate - alleges Kenvue and J&J "intentionally overlooked and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

The case seeks to make the firms "destroy any promotional materials" that states Tylenol is safe for expectant mothers.

The court case parallels the complaints of a assembly of guardians of young ones with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in two years ago.

A federal judge threw out the case, stating research from the plaintiffs' authorities was not conclusive.